Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutraceuticals and Exercise for Chronic Fatigue Syndrome
NCT01471652Phase 2Withdrawn
- Sponsor
- Columbia University
- Start
- Mar 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Coenzyme Q10 mucoadhesive tablets, acetyl-l-carnitine, alpha-lipoic acid, docosahexaenoic acid in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Columbia University. Planned start Mar 2012; status: withdrawn.
02
Drugs
Coenzyme Q10 mucoadhesive tabletsacetyl-l-carnitinealpha-lipoic aciddocosahexaenoic acid
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT01471652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471652.